fbpx
Sign up now!
Don't show this again

Thank you for confirming your subscription!

(And remember, if ever you want to change your email preferences or unsubscribe, just click on the links at the bottom of any email.)

We’re glad you’re enjoying Poultry Health Today.
Access is free but you’ll need to register to view more content.
Already registered? Sign In
Tap to download the app
X
Share
X

REPORTS

Collect articles and features into your own report to read later, print or share with others

Create a New Report

Favorites

Read Later

Create a new report

Report title (required) Brief description (optional)
CREATE
X
NEXT
POULTRY PORK
follow us


You must be logged in to edit your profile.

Favorites Read Later My Reports PHT Special Reports
Poultry Health Today is equipped with some amazing (and free) tools for organizing and sharing content, as well as creating your own magazines and special reports. To access them, please register today.
Sponsored by Zoetis

Sponsored By Zoetis

.
Featured Video Play Icon

Novel technologies needed to combat IB in chickens

Despite decades of vaccination, the world poultry industry’s ongoing battle with infectious bronchitis (IB) continues to rage and points to the need for novel technologies to combat the disease, according to Haroldo Toro, DVM, PhD, Auburn University.

“The industry has done a lot, but we have not been able to control [the disease]. And you know, the first vaccines were produced in the 1950s, and here we are still talking about bronchitis,” Toro told Poultry Health Today.

The IB virus is extremely “successful” and is probably the most economically relevant virus in the poultry industry worldwide. It’s always there, he noted, in contrast to avian influenza, which comes and goes.

When the right IB vaccines are used at the right time, producers can expect reasonably good protection against the IB virus. That’s not always the case, however, because of the changing nature of the IB virus, the lack of cross-protection and the ability of the virus to recombine.

If flocks have IB virus strains A and B, for example, and are vaccinated only against strain A, they won’t be protected against strain B, said Toro, who gave a keynote address titled “Understanding the success of infectious bronchitis virus” at the 2018 American Association of Avian Pathologists conference.

“So, what we need to do is invest in new, novel technologies,” he said.

“Recombinant vaccines induce an immune response but don’t replicate in the host, but there are other vectors that could be used that would express a particular protein in a way that would also produce immunity against IB virus.”

Questions European approach

Toro questioned an approach to IB virus control used in Europe that involves the use of vaccines with serotypes that are said to protect against other serotypes. The approach “doesn’t work,” he asserted, and said researchers have demonstrated it is not effective against US strains of IB virus.

The perceived boost in protection “may be just because of the invasiveness of [a] particular virus strain that they have been using,” he reasoned.  “It just covers all host receptors, and the wild strain is not able to replicate.”

For now, the best strategy is to use diagnostics to identify the strains of IB virus affecting a flock and then use a homologous vaccine — a strain similar to the wild strain that’s causing the problem.

Toro noted his involvement with studies demonstrating that the response to IB vaccines isn’t as good in birds with an immature immune system. “If you have the possibility of postponing your vaccination, you will have a better response,” he said.




Posted on March 27, 2019

tags: ,
RELATED NEWS
  • E. coli vaccination helps contain losses in broilers with IB infection

    Field experience with infectious bronchitis in broilers during a harsh winter demonstrated that vaccination for secondary Escherichia coli infection helped stem losses

  • Consistency, follow-up key to controlling IBV

    Infectious bronchitis virus (IBV) is a “moving target” and trying to keep ahead of it requires consistency and follow-up, explained Sjaak de Wit, DVM, PhD, of GD Animal Health, the Netherlands.

  • Why infectious bronchitis is so resilient — and what broiler companies can do about it

    Control of infectious bronchitis (IB) requires good biosecurity, good management and rigorous administration of a vaccine that matches the circulating virus as closely as possible, John Smith, DVM, MAM, Alectryon LLC, formerly with Fieldale Farms, told Poultry Health...

  • Immune-response research could yield new IB strategies for poultry

    Research into the immune response of chickens could help lead to strategies that enable chickens to resist infectious bronchitis (IB), Rodrigo Gallardo, DVM, PhD, professor, University of California – Davis, told Poultry Health Today.




You must be logged in to edit your profile.

Google Translate is provided on this website as a reference tool. However, Poultry Health Today and its sponsor and affiliates do not guarantee in any way the accuracy of the translated content and are not responsible for any event resulting from the use of the translation provided by Google. By choosing a language other than English from the Google Translate menu, the user agrees to withhold all liability and/or damage that may occur to the user by depending on or using the translation by Google.